VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into Bio-Techne Corporation (TECH) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Life Sciences Tools & Services · market value about $11.4B · P/E 62.6 · revenue $1.2B (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows